Carl L. Gordon, Director, 10% Owner at ArriVent Biopharma, Inc. (AVBP), bought 691,837 shares at $18.00 ($4.0M) on 2024-01-30, disclosed to the SEC on 2024-01-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 469,615 | $0 | 0.0% |
| 2 | $18.00 | 222,222 | $4.0M | 100.0% |
| Total | $5.78 avg | 691,837 | $4.0M | 100% |
| Filing → |
| SCTX | BUY | 2026-07-29 | $15.0M | — | Filing → |
| CMPX | SELL | 2025-04-11 | $11.4M | — | Filing → |
| MBX | BUY | 2025-02-19 | $2.7M | — | Filing → |